← Back to News

BofA Raises Price Target on Pfizer (PFE) Following Strong Q1 Results

neutralMulti dayYahoo Finance ·27 May 2026Original article ↗
Oraklio AI Analysis
Confidence 92%

Pfizer coverage (PFE) cannot be assigned to a ticker because PFE is not present in active_symbols. Therefore this dashboard cannot classify its impact.

Article

BofA Raises Price Target on Pfizer (PFE) Following Strong Q1 Results Sheryar Siddiq Wed, May 27, 2026 at 12:27 PM GMT+2 2 min read PFE Pfizer Inc. (NYSE: PFE ) ranks among the best retirement stocks to buy now . On May 5, BofA Securities boosted its price objective for Pfizer Inc.

(NYSE:PFE) to $27 from $26, retaining a Neutral rating on the company shares. Following Pfizer’s first-quarter performance, the firm raised its fiscal 2026 revenue and earnings per share forecasts. The pharmaceutical giant reported adjusted earnings per share of $0.

75, 4. 17% more than the consensus forecast of $0. 72, while revenue of $14.

5 billion exceeded expectations of $13. 84 billion by 4. 77%.

Ignoring COVID-related products, Pfizer’s core business increased by 7% operationally. BofA remarked that Pfizer’s long-term revenue CAGR target for 2028-2033 is significantly higher than the consensus. BofA sees meeting this aim as questionable and potentially skewed toward obesity therapies, where the market landscape is very competitive.

Additionally, Pfizer Inc. (NYSE:PFE) revealed details regarding a 35-valent pneumococcal conjugate vaccine that is ready for Phase 1. According to BofA, the absence of supporting data and the capacity to resolve protein carrier suppression, a major concern regarding ultra-high valent pneumococcal vaccines, still need to be determined.

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the US and internationally. The company offers medicines and vaccines in various therapeutic areas.

While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock . READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years   Disclosure: None.

Follow Insider Monkey on Google News .

Oraklio AI Trading Intelligence

News is just the start.

Oraklio turns news, price data, and market signals into structured BUY / SELL / NO_TRADE calls — updated continuously throughout the trading day.

Get started free

Already have an account? Sign in →